PLP2 Expression as a Prognostic and Therapeutic Indicator in High-Risk Multiple Myeloma

PLP2 Expression as a Prognostic and Therapeutic Indicator in High-Risk Multiple Myeloma

Multiple myeloma (MM) is a devastating cancer with a highly heterogeneous outcome. Because of the heterogeneity of myeloma cells, risk stratification is important for making therapeutic regimens. Nevertheless, no immunohistochemical predictive and prognostic marker has been constructed yet. In the p...

Full description

Bibliographic Details
Main Authors:	Hua Bai, Yudi Zhu, Peipei Xu, Bing Chen
Format:	Article
Language:	English
Published:	Hindawi Limited 2020-01-01
Series:	BioMed Research International
Online Access:	http://dx.doi.org/10.1155/2020/4286101

Similar Items

Genetic Abnormalities in Multiple Myeloma: Prognostic and Therapeutic Implications
by: Ignacio J. Cardona-Benavides, et al.
Published: (2021-02-01)

Abnormal PTBP1 Expression Sustains the Disease Progression of Multiple Myeloma
by: Hua Bai, et al.
Published: (2020-01-01)

Comprehensive Risk Stratification Model for Prognostication and Assisting with Therapeutic Decision-Making for Multiple Myeloma Patients
by: Song, Brian
Published: (2018)

Prognostic Value of CD56 Expression in Multiple Myeloma
by: Salah Khallaf, et al.
Published: (2020-06-01)

PLP-Dependent Enzymes
by: Alessandro Paiardini, et al.
Published: (2014-01-01)

Therapeutic advancements in multiple myeloma
by: Alessandro eGozzetti, et al.
Published: (2014-09-01)

New prognostic biomarkers in multiple myeloma
by: Aneta Szudy-Szczyrek, et al.
Published: (2016-01-01)

Immunological Prognostic Factors in Multiple Myeloma
by: Dominika Bębnowska, et al.
Published: (2021-03-01)

The Evolution of Prognostic Factors in Multiple Myeloma
by: Amr Hanbali, et al.
Published: (2017-01-01)

Prediction and prognostic significance of BCAR3 expression in patients with multiple myeloma
by: Weilong Zhang, et al.
Published: (2018-12-01)

The prognostic role of p-53 protein Immunohistochemical expression in multiple myeloma
by: Muna A. Abdullah, et al.
Published: (2015-01-01)

Tumour Dissemination in Multiple Myeloma Disease Progression and Relapse: A Potential Therapeutic Target in High-Risk Myeloma
by: Mara N. Zeissig, et al.
Published: (2020-12-01)

Correlation Between Anti-Myelin Proteolipid Protein (PLP) Antibodies and Disease Severity in Multiple Sclerosis Patients With PLP Response-Permissive HLA Types
by: Judith M. Greer, et al.
Published: (2020-08-01)

Molecular Genetic Analysis of the <it>PLP1 </it>Gene in 38 Families with <it>PLP1</it>-related disorders: Identification and Functional Characterization of 11 Novel <it>PLP1 </it>Mutations
by: Marchiani Valentina, et al.
Published: (2011-06-01)

Prognostic factors in paraproteinaemia, treatment of multiple myeloma
by: Al-Rubei, Kastal J.
Published: (1980)

Prognostic and predictive biomarker developments in multiple myeloma
by: Craig T. Wallington-Beddoe, et al.
Published: (2021-09-01)

Prognostic Nomogram for the Overall Survival of Patients with Newly Diagnosed Multiple Myeloma
by: Yue Zhang, et al.
Published: (2019-01-01)

The significance of prognostic profiling in the treatment of patients with multiple myeloma
by: Mitrović Marko, et al.
Published: (2020-01-01)

Frequency and prognostic significance of hypercalcemia in patients with multiple myeloma
by: Kanar J Karim, et al.
Published: (2020-01-01)

MMSET: Role and Therapeutic Opportunities in Multiple Myeloma
by: Zhigang Xie, et al.
Published: (2014-01-01)

Possible Therapeutic Potential of Disulfiram for Multiple Myeloma
by: Denisa Weiser Drozdkova, et al.
Published: (2021-06-01)

HLA-E Binding Peptide as a Potential Therapeutic Candidate for High-Risk Multiple Myeloma
by: Ying Yang, et al.
Published: (2021-06-01)

hsa_circRNA_101237: A Novel Diagnostic and Prognostic Biomarker and Potential Therapeutic Target for Multiple Myeloma
by: Liu X, et al.
Published: (2020-03-01)

The effects of increased Plp1 gene dosage on expression and processing of myelin proteins
by: Karim, Saadia Ansari
Published: (2007)

Comprehensive profiling of circular RNA expressions reveals potential diagnostic and prognostic biomarkers in multiple myeloma
by: Fan Zhou, et al.
Published: (2020-01-01)

The prognostic and predictive value of IKZF1 and IKZF3 expression in T-cells in patients with multiple myeloma
by: Mohamed H. S. Awwad, et al.
Published: (2018-10-01)

Speech recognition by clustering wavelet and PLP coefficients
by: Er, Chiangkai
Published: (2008)

Computational Studies Addressed to PLP-Dependent Enzymes
by: Henrique Silva Fernandes
Published: (2021)

Pathogenetic and Prognostic Implications of Increased Mitochondrial Content in Multiple Myeloma
by: Yanira Ruiz-Heredia, et al.
Published: (2021-06-01)

Natural History and Prognostic Factors at First Relapse in Multiple Myeloma
by: Chen Wang, et al.
Published: (2020-07-01)

Prognostic value of 1q21 amplification in multiple myeloma
by: T V Abramova, et al.
Published: (2017-07-01)

Fatores prognósticos no Mieloma Múltiplo Prognostic factors in Multiple Myeloma
by: Gracia A. Martinez
Published: (2007-03-01)

Prognostic Potential of Heart Rate and Hypertension in Multiple Myeloma Patients
by: Jie Wang, et al.
Published: (2021-09-01)

The perspectives of interleukin-10 in the pathogenesis and therapeutics of multiple myeloma
by: Cheng-Der Liu, et al.
Published: (2021-01-01)

Proteasome inhibition and its therapeutic potential in multiple myeloma
by: Ajai Chari, et al.
Published: (2010-09-01)

PRMT5 regulates cell pyroptosis by silencing CASP1 in multiple myeloma
by: Tian Xia, et al.
Published: (2021-09-01)

High Expression of Succinate Dehydrogenase Subunit A Which Is Regulated by Histone Acetylation, Acts as a Good Prognostic Factor of Multiple Myeloma Patients
by: Yifeng Sun, et al.
Published: (2020-09-01)

Expression of PRAME gene in multiple myeloma
by: I В Abramenko, et al.
Published: (2004-07-01)

The study of expressed genes in multiple myeloma
by: Dring, Ann Marie
Published: (2004)

V-Domain Ig Suppressor of T Cell Activation (VISTA) Expression Is an Independent Prognostic Factor in Multiple Myeloma
by: Pim Mutsaers, et al.
Published: (2021-05-01)